Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFrontier Dev Regulatory News (FDEV)

Share Price Information for Frontier Dev (FDEV)

Share Price is delayed by 15 minutes
Get Live Data
461.50    5.00 (1.10%)
Bid:
455.50
Ask:
460.00
Spread: 4.50 (0.988%)
Market Cap: £160.29m
FDEV Live PriceLast checked at - London Stock Exchange

Intraday Frontier Dev Share Chart

Business Update

27 May 2016 07:00

RNS Number : 4764Z
Frontier Developments PLC
27 May 2016
 

27 May 2016

 

Frontier Developments plc

 

Business Update

 

Frontier Developments plc (AIM: FDEV, "Frontier", the "Group"), a leading developer of video games, announces the following update.

Elite: Dangerous

Frontier yesterday launched the next major expansion of Elite Dangerous: Horizons, 'The Engineers'. This release comes slightly earlier than previously anticipated following a successful Beta period, and in combination with sales performance to date, will have a positive impact on revenues and profitability in the financial year to 31 May 2016. The Group has also announced that it plans to release Elite Dangerous: Horizons for Xbox One on 3 June.

Planet Coaster

Frontier released the second Alpha build of Planet Coaster, the Group's second self-published franchise, on schedule on 24 May. The Alpha 2 build delivers further creative tools to the Planet Coaster Alpha community including terrain deformation and the next iteration of coaster construction and is a step along the roadmap towards full release, which remains on track for the final quarter of 2016.

David Braben, Chief Executive of Frontier Developments, said:

"The six week additional development time before the release of 'The Engineers' has greatly improved the quality of the game overall. Due to the success of the beta, we have managed to release a few days earlier than originally expected.

Planet Coaster continues to progress well and we continue to receive highly encouraging feedback. The full release in the final calendar quarter of 2016 will complete our transition to fully self-publishing our own output."

Enquiries:

Frontier Developments

+44 (0)1223 394 300

David Braben, CEO

David Walsh, COO

Neil Armstrong, CFO

 

 

 

Numis - Nomad and Joint Broker

+44 (0)20 7260 1000

Simon Willis/Jamie Lillywhite/Toby Adcock

 

 

 

Finncap

+44 (0) 207 220 0500

Matt Goode/Giles Rolls

 

 

 

Tulchan Communications

+44 (0) 207 353 4200

James Macey White/Matt Low

 

 

Important Note

The information contained in this announcement about the sales of Elite: Dangerous and Planet Coaster does not constitute a profit estimate or profit forecast in respect of the Group or any guidance as to the likely profits of the Group.

 

About Frontier Developments plc 

Frontier Developments plc, quoted on the AIM market of the London Stock Exchange (AIM: FDEV), is a leading independent game developer founded in 1994 by David Braben, co-author of the seminal 'Elite' game.

Based in Cambridge, Frontier uses its proprietary 'COBRA' game development technology to create innovative games across videogame consoles, computers, smartphones and tablets.

Notes to Editors

Alpha and Beta are common terms used to describe pre-release versions of software. Alpha releases are typically focused on a limited feature set compared to the final version, whilst Beta releases approach full functionality with some aspects remaining work-in-progress.

www.frontier.co.uk 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUNUKRNOAVUAR
Date   Source Headline
1st Jun 202612:05 pmRNSEBT Share Purchase
28th May 20262:30 pmRNS-RPlanet Zoo 2 Announced
22nd May 202611:26 amRNS-RWarhammer 40,000: Chaos Gate – Deathwatch Revealed
22nd May 20269:16 amRNSHolding(s) in Company
19th May 20265:47 pmRNSHolding(s) in Company
18th May 202610:48 amRNSEBT Share Purchase
12th May 20267:00 amRNSTrading Update - FY26 Revenue & Profit Upgraded
23rd Apr 20267:00 amRNSCompletion of Share Buyback Programme
23rd Apr 20267:00 amRNSDirector/PDMR Shareholding
23rd Apr 20267:00 amRNSTransaction in Own Shares
22nd Apr 202611:05 amRNSHolding(s) in Company
22nd Apr 20267:00 amRNSDirector/PDMR Shareholding
22nd Apr 20267:00 amRNSTransaction in Own Shares
21st Apr 20267:00 amRNSTransaction in Own Shares
17th Apr 20267:00 amRNSDirector/PDMR Shareholding
17th Apr 20267:00 amRNSTransaction in Own Shares
16th Apr 20267:00 amRNSDirector/PDMR Shareholding
16th Apr 20267:00 amRNSTransaction in Own Shares
15th Apr 20267:00 amRNSDirector/PDMR Shareholding
15th Apr 20267:00 amRNSTransaction in Own Shares
14th Apr 20267:00 amRNSDirector/PDMR Shareholding
14th Apr 20267:00 amRNSTransaction in Own Shares
10th Apr 20267:00 amRNSDirector/PDMR Shareholding
10th Apr 20267:00 amRNSTransaction in Own Shares
9th Apr 20267:00 amRNSDirector/PDMR Shareholding
8th Apr 20267:00 amRNSDirector/PDMR Shareholding
8th Apr 20267:00 amRNSTransaction in Own Shares
7th Apr 20267:00 amRNSDirector/PDMR Shareholding
7th Apr 20267:00 amRNSTransaction in Own Shares
2nd Apr 20267:00 amRNSDirector/PDMR Shareholding
2nd Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 20267:00 amRNSDirector/PDMR Shareholding
1st Apr 20267:00 amRNSTransaction in Own Shares
31st Mar 20267:00 amRNSDirector/PDMR Shareholding
31st Mar 20267:00 amRNSTransaction in Own Shares
30th Mar 20267:00 amRNSDirector/PDMR Shareholding
30th Mar 20267:00 amRNSTransaction in Own Shares
27th Mar 20267:00 amRNSDirector/PDMR Shareholding
27th Mar 20267:00 amRNSTransaction in Own Shares
26th Mar 20267:00 amRNSDirector/PDMR Shareholding
26th Mar 20267:00 amRNSTransaction in Own Shares
25th Mar 20267:00 amRNSDirector/PDMR Shareholding
25th Mar 20267:00 amRNSTransaction in Own Shares
24th Mar 20267:00 amRNSDirector/PDMR Shareholding
24th Mar 20267:00 amRNSTransaction in Own Shares
23rd Mar 20267:00 amRNSDirector/PDMR Shareholding
23rd Mar 20267:00 amRNSTransaction in Own Shares
20th Mar 20267:00 amRNSDirector/PDMR Shareholding
20th Mar 20267:00 amRNSTransaction in Own Shares
19th Mar 20267:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.